Skip to main content

Table 3 Distribution of prostate cancer T stage before and after PSMA-PET imaging of the prostate

From: Integration of 68Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study

T stage Initial clinical Staging: n (%) Relative up-staging by PSMA-PET-imaging: n (%) Relative down-staging by PSMA-PET-imaging: n (%) PSMA-PET-imaging staging: n (%)
Biopsy T1c 6 (40.0) 1 (6.7) 1 (6.7) 0
Low risk (≤T2a) 0 0 0 2 (13.3)
Intermediate risk (T2b) 2 (13.3) 1 (6.7) 0 1 (6.7)
High risk (≥T2c) 7 (46.7) 4 (26.7) 1 (6.7) 12 (80.0)